brand semaglutide FDA warns about safety of 'off-brand' versions of Ozempic, Wegovy Compounded Semaglutide vs Brand Name

By: Kristin Brooks Managing Editor, Contract Pharma For pharma manufacturers, the growth of GLP-1 drugs to treat conditions such as diabetes and obesity has placed increased strain on the supply chain and subsequent pressure to avoid bottle necks

The drug would be prescribed to patients who are obese or overweight and have at least one comorbid condition

With Retatrutide: similar GI effects, plus in some cases additional sensations (e.g

DOI: 10.1016/j.bcp.2017.11.007 Liu JR, Deng ZH, Zhu XJ, Zeng YR, Guan XX, Li JH

Key Takeaways Compounded semaglutide shares the same active molecule as Ozempic and Wegovy, a GLP-1 receptor agonist , but the finished product is made by a compounding pharmacy and is not FDA-approved

It is, after all, a medication you inject subcutaneously and that enters systemic circulation